Scheme 1

Preparation of nanoformulations and a dual–trigger release of SA under pH/GSH. Illustration of SA releases into HL60 cells and possible mechanism of actions along with molecular targets especially lncRNAs and MMPs and their expression/level status detected in cells compared to control HL60 cells without treatments